In dry AMD models, ISM9077 significantly improved retinal structural integrity and visual function. (IMAGE)
Caption
On key evaluation endpoints, ISM9077 demonstrated efficacy approximately three times of currently available therapy, while simultaneously demonstrating superior histopathological improvement.
Credit
Insilico Medicine
Usage Restrictions
None
License
Original content